Status:
ACTIVE_NOT_RECRUITING
Examining Feasibility and Acceptability of Telemedicine for Substance Use Disorder (SUD)
Lead Sponsor:
University of Michigan
Conditions:
Substance Use Disorders
Substance Use
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The objective of this pilot intervention study is to iteratively refine motivational interviewing and psychosocial intervention programs delivered via telehealth (Teletx) to help improve substance use...
Eligibility Criteria
Inclusion
- Outpatient care at Michigan Medicine in past year
- Diagnostic and Statistical Manual of Mental Disorders (DSM-5) SUD diagnosis and/or substance use on average of 2 days a week over the past month
- Have a Smart phone, tablet or another Wi-Fi or data-enabled device (e.g. with a camera)
Exclusion
- Inability to speak or understand English
- Conditions that preclude informed consent (e.g., acute psychosis, cognitive deficits) or understanding of assessment or program content
- Prior alcohol withdrawal seizures or delirium tremens (DTs). Those who are at-risk of complicated withdrawal (e.g., seizures, DTs) require greater medical attention and will be excluded and referred to their clinician for medical management.
Key Trial Info
Start Date :
November 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04768920
Start Date
November 11 2022
End Date
February 28 2026
Last Update
July 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48109